Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Efficacy and quality of life for FOLFOX/bevacizumab +/− irinotecan in first-line metastatic colorectal cancer—final results of the AIO CHARTA trial

    FOLFOXIRI plus bevacizumab has demonstrated benefits for metastatic colorectal cancer (mCRC) patients. However, challenges arise in its clinical implementation due to expected side effects and a lack of strati...

    Hans-Joachim Schmoll, Julia Mann, Fabian Meinert in British Journal of Cancer (2024)

  2. No Access

    Living Reference Work Entry In depth

    Regionale Chemotherapie bei extrahepatischen Tumoren/Metastasen

    Während die leberarterielle Chemotherapie einen gewissen Stellenwert in der Behandlung von Lebermetastasen kolorektaler Karzinome besitzt, sind die Daten zur regionalen Chemotherapie von extrahepatischen Tumor...

    Bert Hildebrandt, Bernhard Gebauer in Kompendium Internistische Onkologie

  3. No Access

    Living Reference Work Entry In depth

    Regionale Chemotherapie/Chemoembolisation von Lebermetastasen

    Regionale Therapieverfahren werden zur gezielten Behandlung eines tumor- oder metastasentragenden Organs oder Organsystems eingesetzt. Sie werden einerseits von den lokalen (z. B. chirurgischen oder ablativen)...

    Bert Hildebrandt, Bernhard Gebauer in Kompendium Internistische Onkologie

  4. No Access

    Living Reference Work Entry In depth

    Lokoregionäre Radionuklidtherapie

    Die lokoregionäre Radionuklidtherapie ist eine Form der Brachytherapie (griech. brachys: kurz, nah), bei der ein radioaktiver Strahler auf venösem Weg für die Radiopeptidtherapie (RPT) bzw. Peptid-Rezeptor-Rad...

    Isabel Schobert, Bert Hildebrandt, Holger Amthauer in Kompendium Internistische Onkologie

  5. Article

    Open Access

    Upfront FOLFOXIRI+bevacizumab followed by fluoropyrimidin and bevacizumab maintenance in patients with molecularly unselected metastatic colorectal cancer

    The addition of bevacizumab (BEV) to standard doublet chemotherapy improves outcomes compared with chemotherapy alone in patients with metastatic colorectal cancer (mCRC). The OPAL study examined the effect of...

    Alexander Stein, Djordje Atanackovic, Bert Hildebrandt in British Journal of Cancer (2015)

  6. Article

    Open Access

    Interventionally implanted port catheter systems for hepatic arterial infusion of chemotherapy in patients with primary liver cancer: A phase II-study (NCT00356161)

    Hepatic arterial infusion (HAI) of chemotherapy requires the implantation of a transcatheter application system which is traditionally performed by surgery. This procedure, but particularly the adjacent drug a...

    Marianne Sinn, Annett Nicolaou, Jens Ricke, Pjotr Podrabsky in BMC Gastroenterology (2013)

  7. No Access

    Article

    Matched-Pair Comparison of Radioembolization Plus Best Supportive Care Versus Best Supportive Care Alone for Chemotherapy Refractory Liver-Dominant Colorectal Metastases

    This study was designed to evaluate overall survival after radioembolization or best supportive care (BSC) in patients with chemotherapy-refractory liver-dominant metastatic colorectal cancer (mCRC).

    Ricarda Seidensticker, Timm Denecke in CardioVascular and Interventional Radiology (2012)

  8. Article

    Open Access

    Treatment with bevacizumab and FOLFOXIRI in patients with advanced colorectal cancer: presentation of two novel trials (CHARTA and PERIMAX) and review of the literature

    More than half of patients with colorectal cancer will develop metastatic disease either evident at the time of initial diagnosis or during their course of disease. Besides multidisciplinary management further...

    Alexander Stein, Gabriel Glockzin, Andreas Wienke, Dirk Arnold in BMC Cancer (2012)

  9. No Access

    Chapter

    Induced Hyperthermia in the Treatment of Cancer

    The term “hyperthermia” summarizes the treatment of malignant diseases by application of heat by using different techniques. Hyperthermia is usually applied as an adjunct to an established treatment modality c...

    Bert Hildebrandt, Johanna Gellermann in Cancer Management in Man: Chemotherapy, Bi… (2011)

  10. No Access

    Article

    Thrombocytopenia as first manifestation of splenic angiosarcoma

    Simon Raffel, Bert Hildebrandt, Christian Grieser, Stefan Pahl in Annals of Hematology (2010)

  11. No Access

    Article

    Adult jejunojejunal intussusception caused by metastasized pleomorphic carcinoma of the lung: Report of a case

    Adult small-intestinal intussusception is rare and very different from childhood intussusception. Both benign and malignant pathologies can underlie small intestinal intussusception in adults, but malignancy i...

    Baomin Shi, Gereon Gaebelein, Bert Hildebrandt, Wilko Weichert in Surgery Today (2009)

  12. No Access

    Article

    Phase II Feasibility Study on the Combination of Two Different Regional Treatment Approaches in Patients with Colorectal “Liver-Only” Metastases: Hepatic Interstitial Brachytherapy Plus Regional Chemotherapy

    The aim of this study was to evaluate the feasibility, safety, and efficacy of combined treatment with hepatic interstitial brachytherapy (HIB) and hepatic arterial infusion (HAI) of chemotherapy after interve...

    Gero Wieners, Maciej Pech, Bert Hildebrandt in CardioVascular and Interventional Radiology (2009)

  13. No Access

    Chapter

    Perfusion Scintigraphy with Integrated Single Photon Emission Computed Tomography/Computed Tomography in the Management of Transarterial Treatment of Hepatic Malignancies

    During the recent years it has been shown that transarterial applications of anticancer agents are promising approaches in the treatment of hepatic malignancies. While new techniques led to a reappraisal of he...

    Timm Denecke, Bert Hildebrandt, Enrique Lopez-Hänninen in Liver Cancer (2009)

  14. No Access

    Article

    Planning transarterial radioembolization of colorectal liver metastases with Yttrium 90 microspheres: evaluation of a sequential diagnostic approach using radiologic and nuclear medicine imaging techniques

    The purpose of the study was to establish a diagnostic approach to the preparation of patients with colorectal liver metastases considered for transarterial radioembolization (RE). Twenty-two patients sequenti...

    Timm Denecke, Ricarda Rühl, Bert Hildebrandt, Lars Stelter in European Radiology (2008)

  15. Article

    Open Access

    Interventionally implanted port catheter systems for hepatic arterial infusion of chemotherapy in patients with colorectal liver metastases: A phase II-study and historical comparison with the surgical approach

    The high complication rates of surgically implanted port catheter systems (SIPCS) represents a major drawback in the treatment of isolated liver neoplasms by hepatic arterial infusion (HAI) of chemotherapy. In...

    Bert Hildebrandt, Maciej Pech, Annett Nicolaou, Jan M Langrehr, Jacek Kurcz in BMC Cancer (2007)

  16. No Access

    Chapter

    The Biologic Rationale of Hyperthermia

    Bert Hildebrandt, Peter Wust in Peritoneal Carcinomatosis (2007)

  17. No Access

    Chapter

    Interactions between Hyperthermia and Cytotoxic Drugs

    Bert Hildebrandt, Peter Wust in Peritoneal Carcinomatosis (2007)

  18. No Access

    Article

    Adjuvant chemotherapy with folinic acid and 5-fluorouracil in patients with locally advanced rectal cancer previously treated by preoperative radiochemotherapy and curative tumor resection

    The role of postoperative adjuvant chemotherapy in patients with rectal cancer pretreated by preoperative radiochemotherapy (RCT) and curative surgery is still poorly investigated.

    Bert Hildebrandt, Beate Rau, Jürgen Löffel in International Journal of Colorectal Disease (2006)

  19. Article

    Open Access

    Genetic dissection of apoptosis and cell cycle control in response of colorectal cancer treated with preoperative radiochemotherapy

    In previous analyses we identified therapy-induced upregulation of the CDK inhibitor p21CIP/WAF-1 and consequently decreased tumor cell proliferation or loss of Bax as adverse factors for survival in rectal cance...

    Isrid Sturm, Beate Rau, Peter M Schlag, Peter Wust, Bert Hildebrandt in BMC Cancer (2006)

  20. Article

    Open Access

    A non-randomised, single-centre comparison of induction chemotherapy followed by radiochemotherapy versus concomitant chemotherapy with hyperfractionated radiotherapy in inoperable head and neck carcinomas

    The application of induction chemotherapy failed to provide a consistent benefit for local control in primary treatment of advanced head and neck (H&N) cancers. The aim of this study was to compare the results...

    Reinhold Graf, Bert Hildebrandt, Wolfgang Tilly, Hanno Riess, Roland Felix in BMC Cancer (2006)

previous disabled Page of 2